The Features of COVID-19's Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Ptushkin, Vadim; Arshanskaya, Evgeniya; Vinogradova, Olga; Kudlay, Dmitry; Nikitin, Eugene

Ptushkin, Vadim; Arshanskaya, Evgeniya; Vinogradova, Olga; Kudlay, Dmitry; Nikitin, Eugene.

Afiliação

Ptushkin V; Moscow City Hematology Center, S.P. Botkin City Clinical Hospital, Moscow 125284, Russia.
Arshanskaya E; Department of Oncology, Hematology and Radiation Therapy, Pirogov Russian National Research Medical University, Moscow 117997, Russia.
Vinogradova O; Moscow City Hematology Center, S.P. Botkin City Clinical Hospital, Moscow 125284, Russia.
Kudlay D; Moscow City Hematology Center, S.P. Botkin City Clinical Hospital, Moscow 125284, Russia.
Nikitin E; Department of Oncology, Hematology and Radiation Therapy, Pirogov Russian National Research Medical University, Moscow 117997, Russia.

Hematol Rep ; 15(3): 503-512, 2023 Sep 01.

Article em En | MEDLINE | ID: mdl-37754667

Palavras-chave

COVID-19; Gam-COVID-Vac; SARS-CoV-2; anti-SARS-CoV-2 IgG; eculizumab; paroxysmal nocturnal hemoglobinuria

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hematol Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Federação Russa País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google